HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Claims Other Than COVID-19 Surface But Contaminated Sanitizer Spreads In US Warnings

Executive Summary

FDA inspectors in the eastern US took their turn recently at finding violations for dietary supplement manufacturing marketing unrelated to COVID-19. Agency also warned two more Mexican businesses that exploited its temporary loosening of regulations for producing alcohol-based hand sanitizers.

You may also be interested in...

‘Serrapeptase,’ Alfalfa, Olive Leaf Linked To Drug Claims In Warnings To US Supplement Firms

World Nutrition, Eagles Song Health and Wellness and Natural Sprout Co. received warning letters in late October from FDA's ORA Operations Division West identifying violative claims including “greens are alkalizing to the body, disease won't thrive in an alkaline body," and “alfalfa may help reduce cholesterol.”

US FDA Calls And Three Mexican Firms Recall Contaminated Sanitizers, But A Fourth Hangs Up

Four warnings, like previous letters FDA submitted to Mexican firms making methanol-containing hand sanitizers, which have been linked to deaths and other adverse events, indicate the targeted firms apparently entered US market for the products after the agency loosened manufacturing controls.

US FDA Adds Hand Sanitizer Import Alert Category After COVID-19 Production Surge Turned Deadly

Action responds to methanol contamination in hand sanitizers manufactured in Mexico and marketed in the US under numerous brands that followed a loosening standards for the products to drive a swift increase in production and meet surging demand during the coronavirus pandemic.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts